Lbx Pharmacy Chain 老百姓
31 significant filings since 30 May 2026: 1 on share pledge, 20 on equity incentive and 5 on buyback, and 3 other kinds. The latest, on 15 Sep 2026: 关于以集中竞价方式首次回购股份的进展公告.
自 30 May 2026 起有 31 份重大公告：share pledge 1 份、equity incentive 20 份、buyback 5 份，另有 3 类。最新一份（15 Sep 2026）：关于以集中竞价方式首次回购股份的进展公告。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥13.04 · Low 最低 ¥12.83 · +0.39% on the previous close of ¥12.90The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 31 Oct 2023 | 东莞证券 | 魏红梅 | Outperform 增持 | ▲ | Buy 买入 |
| 1 Sep 2023 | 东莞证券 | 魏红梅,谢雄雄 | Buy 买入 | ▼ | Outperform 增持 |
| 21 Aug 2020 | 东莞证券 | 魏红梅,雷国轩 | Outperform 增持 | ▲ | Buy 买入 |
| 31 Oct 2019 | 华金证券 | 周新明,王睿 | Outperform 增持 | ▲ | Buy 买入 |
| 31 Oct 2019 | 国元证券 | 黄卓 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 中邮证券 | 盛丽华,龙永茂 | Buy 买入 | 17 Sep 2026 | 1 | — |
| 东海证券 | 杜永宏 | Buy 买入 | 9 Sep 2026 | 2 | — |
| 东吴证券 | 朱国广,冉胜男,苏丰 | Buy 买入 | 1 Sep 2026 | 3 | — |
| 国信证券 | 陈曦炳,彭思宇,贾瑞祥 | Outperform 增持 | 30 Aug 2026 | 2 | — |
| 开源证券 | 余汝意,巢舒然 | Buy 买入 | 28 Apr 2026 | 1 | — |
| 西南证券 | 杜向阳,汪翌雯 | Unrated | 11 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 10 reports. 每行为该券商近十二个月的最新研报；10 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。